Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.
Press releases published on July 25, 2025
Enkrypt AI Releases Agent Risk Taxonomy to Secure Autonomous AI Systems
EIN Presswire
·
July 25, 2025
Agent Risk Taxonomy delivers actionable guidance for managing autonomous AI risks in real-world enterprise environments. BOSTON, MA, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- Enkrypt AI today announced the release of its **Agent Risk Taxonomy …
Zakipoint Health Inc. and Cobalt Benefits Partner to Deliver Personalized, Data-Driven Member Experience
EIN Presswire
·
July 25, 2025
zakipoint Health and Cobalt Benefits Group partner to deliver a smarter, personalized member experience through data, AI, and the JoinHealth™ platform. CAMBRIDGE, MA, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- zakipoint Health Inc. and Cobalt …
Lucia Mare’s Memoir 'Resilience' Is a Testament to the Power of Hope and Grit
EIN Presswire
·
July 25, 2025
BOSTON, MA, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- Lucia Mare’s Resilience: A Story of Courage, Love, Hope and Faith is more than a memoir—it’s a deeply moving testament to the human spirit’s ability to overcome, endure, and transform. A …
WelcomeNST Receives $170K Grant From The Church of Jesus Christ of Latter-day Saints to Support Refugee & SIV Families
EIN Presswire
·
July 25, 2025
Partnership Will Help Communities Provide Housing, Food, and Essentials MARLBOROUGH, MA, UNITED STATES, July 25, 2025 /EINPresswire.com/ -- WelcomeNST, a nonprofit organization that mobilizes communities to welcome and support refugee families, has been …
AMG to Announce Second Quarter Results on July 31, 2025
GlobeNewswire
·
July 25, 2025
Conference Call Scheduled for 11:00 a.m. Eastern Time WEST PALM BEACH, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- AMG (NYSE: AMG) will report financial and operating results for the second quarter ended June 30, 2025 on Thursday, July 31, 2025. A conference …
iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering
GlobeNewswire
·
July 25, 2025
WOBURN, Mass., July 25, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers …
Northeast Bank Announces New Date for Fiscal 2025 Fourth Quarter Earnings Conference Call
GlobeNewswire
·
July 25, 2025
PORTLAND, Maine, July 25, 2025 (GLOBE NEWSWIRE) -- Northeast Bank (the “Bank”) (NASDAQ: NBN), a Maine-based bank, announced today that the Bank will host a conference call with a simultaneous webcast at 1:00 p.m. ET on Tuesday, July 29, 2025 to discuss the …
Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million
GlobeNewswire
·
July 25, 2025
The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol “IMA” at market open on Monday, July 28, 2025 ImageneBio, Inc. will continue to drive the ongoing Phase 2b clinical trial of non- …
MACOM Completes Transfer of RTP Wafer Fab
GlobeNewswire
·
July 25, 2025
LOWELL, Mass., July 25, 2025 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Holdings, Inc. (“MACOM”) (Nasdaq: MTSI), a leading supplier of semiconductor products, today announced it has assumed full operational control of the wafer fabrication facility it …
ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression
GlobeNewswire
·
July 25, 2025
CAMBRIDGE, Mass., July 25, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending marketing authorization for …
Sobi Announces U.S. Food and Drug Administration Approves Doptelet® (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)
GlobeNewswire
·
July 25, 2025
Doptelet Sprinkle (avatrombopag) was approved as an effective formulation for children one year to less than six years. The primary endpoint was met in 27.8% of patients, confirming the efficacy in children and adolescents with persistent or chronic ITP …